Harmony Biosciences (HRMY) – Hot FDA News
-
Harmony Biosciences (HRMY) Announces Positive Topline Data From Phase 2 Signal Detection Study Evaluating Pitolisant In Adult Patients With Myotonic Dystrophy Type 1
-
Harmony Biosciences (HRMY) Falls 14% Following Data From Phase 3 Intune Study of pitolisant in IH
-
Back to HRMY Stock Lookup